The XRT itself consisted of a fractionated 45 Gy. The researchers concluded that CMT significantly improved relapse-free and overall survival rates. This study, conducted by several clinical trial groups in the U.S. and Canada, is the first large study to find a treatment combination that substantially and meaningfully improves the cure of this disease. The researchers noted, however, that 35.4 percent of trial participants had major or minor deviations in XRT protocol at the time of the pre-treatment review. Educational programs to address this new indication for XRT are needed.
Stomach cancer is the second leading cancer killer in the world.
Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer. All rights reserved.